GLP 1

9 min read

GLP-1 Medications and Aging: How Effectiveness Changes After 60

Starting a GLP-1 medication after 60 raises questions that don’t get asked as often as they should. Most of the clinical trial data, the…

10 min read

GLP-1 Medications and Perimenopause: What Changes and Why

Perimenopause is one of the most metabolically turbulent periods in a woman’s life, and it’s also one where GLP-1 medications are increasingly being prescribed….

8 min read

GLP-1 Medications for Men Over 40: Testosterone, Metabolism, and Results

Weight loss for men over 40 operates under a different set of biological conditions than it did in your 20s or 30s, and GLP-1…

9 min read

Long-Term Weight Loss Success on GLP-1: Habits That Actually Stick

GLP-1 medications are among the most effective weight loss tools ever developed, but they don’t produce identical long-term outcomes for everyone who takes them….

9 min read

GLP-1 Maintenance vs Active Weight Loss: How Dosing Strategy Changes

Most of the conversation around GLP-1 medications focuses on the active weight loss phase: how fast results come, what side effects to expect, and…

8 min read

Yoga and GLP-1: Flexibility, Recovery & Mental Health Benefits

Yoga doesn’t burn enough calories to drive weight loss on its own. A 60-minute Hatha class burns roughly 175 to 250 calories.

8 min read

Why Does My GLP-1 Not Work Anymore: Tolerance Decoded

The drug almost certainly still works.

8 min read

Why GLP-1 Medications Keep Running Out: Supply Chain Explained

The FDA lists GLP-1 medications as no longer in shortage in 2026, yet patients still call multiple pharmacies trying to find their dose.

7 min read

What Is PT-141 and How Does It Work?

PT-141, also known by its generic name bremelanotide and the brand name Vyleesi, is a melanocortin receptor agonist used for low sexual desire.

Stay on Track

Join our community and receive:
Expert tips on maximizing your GLP-1 treatment.
Exclusive discounts on your next order.
Updates on the latest weight-loss breakthroughs.